Skip to main content
. 2020 Nov 27;8(2):e001856. doi: 10.1136/bmjdrc-2020-001856

Figure 1.

Figure 1

Flow chart of patient inclusion and exclusion. SGLT2I, sodium-glucose cotransporter 2 inhibitor; T1D, type 1 diabetes; T2D, type 2 diabetes.